Abcam will be attending the 2nd World Congress on Targeting Mitochondria - Strategies, innovations and clinical applications, which will take place in Berlin on October 20-21, 2011 at the Ritz-Carlton Hotel.
In this exciting meeting the role of mitochondria as potential clinical target will be discussed. Mitochondrial dysfunctions are associated with a vast number of pathologies such as cancer, diabetes and neurodegenerative diseases to name a few. It is becoming a necessity to understand how we can target the mitochondria with bioactive molecules or drugs in order to treat and/or prevent those pathologies.
The two main discussion topics of the meeting will be the recent advances on the role of mitochondria in chronic diseases (and which therapeutic strategies can be followed) and the relationship between mitochondria and aging, playing a special interest in how antioxidants are involved in this process.
Our Abcam staff will be on hand to discuss and troubleshoot any problems you may be having within the mitochondrion field, as well happily discussing our new tools for mitochondria detection and mitochondrial assays.
Also, we'll have a special offer for those of you who drop by to say hello!

There are no comments for this entry.
[Add Comment]